The 2nd Biosimilar Market Access and Commercialization Strategies Summit 2018 covers topics such as:
- The Role of Biosimilar Pharmacovigilance Regulations
- Overcoming the Global Challenges of Biosimilar Development
- Recognizing Specific Obstacles to the Adoption of Biosimilars
- Optimizing Pricing Strategies to Gain a Better Market Position
- The Challenges When Obtaining Approval and Sustaining Market Success
- Biosimilar Medicine Trials in the NHS
The 2nd Biosimilar Market Access and Commercialization Strategies Summit 2018 brings together:
- Biologics/Biotechnology/Biogenerics
- Biosimilars
- Market Access Commercialization
- Biopharmaceuticals/Biotherapeutics
- Strategic/Corporate Planning
- Marketing and Sales
- HEOR and Outcomes Research
- Pricing and Reimbursement
- Intellectual Property
- Legal Affairs
- Manufacturing/Bioprocesses
- Medical Affairs
- Regulatory Affairs
- Clinical Affairs/Operations/ Development
- R&D
- Medical Science Liaisons
- CROs/CMOs/CMDOs
- Quality Control/Assurance
- API Manufacturers
- Law Firms
- Consulting Companies
- Distributors
- Licensing Services
- Market Access Service Providers
- Packaging and Labeling Companies
- Distribution and Logistics Services
- Preclinical/Nonclinical/Analytical Development Research Organizations
